Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anti-MATK antibody (Internal) (STJ93960) | Login | Anti-MATK antibody (Internal) (STJ93960) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAP3K13 antibody (151-200 aa) (STJ93975) | Login | Anti-MAP3K13 antibody (151-200 aa) (STJ93975) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGI2 antibody (221-270 aa) (STJ93992) | Login | Anti-MAGI2 antibody (221-270 aa) (STJ93992) | ||||||||||||||||
|
||||||||||||||||||
Anti-SCGB2A2 antibody (41-90 aa) (STJ93996) | Login | Anti-SCGB2A2 antibody (41-90 aa) (STJ93996) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAP2 antibody (14-63 aa) (STJ94001) | Login | Anti-MAP2 antibody (14-63 aa) (STJ94001) | ||||||||||||||||
|
||||||||||||||||||
Anti-MARK2 antibody (10-59 aa) (STJ94016) | Login | Anti-MARK2 antibody (10-59 aa) (STJ94016) | ||||||||||||||||
|
||||||||||||||||||
Anti-MMP7 antibody (218-267 aa) (STJ94028) | Login | Anti-MMP7 antibody (218-267 aa) (STJ94028) | ||||||||||||||||
|
||||||||||||||||||
Anti-ST14 antibody (10-59 aa) (STJ94029) | Login | Anti-ST14 antibody (10-59 aa) (STJ94029) | ||||||||||||||||
|
||||||||||||||||||
Anti-MCL1 antibody (91-140 aa) (STJ94044) | Login | Anti-MCL1 antibody (91-140 aa) (STJ94044) | ||||||||||||||||
|
||||||||||||||||||
Anti-MDM4 antibody (336-385 aa) (STJ94058) | Login | Anti-MDM4 antibody (336-385 aa) (STJ94058) | ||||||||||||||||
|
||||||||||||||||||
Anti-KDR antibody (917-966 aa) (STJ93088) | Login | Anti-KDR antibody (917-966 aa) (STJ93088) | ||||||||||||||||
|
||||||||||||||||||
Anti-Flk-1/Flt-4 antibody (1020-1069 aa) (STJ93091) | Login | Anti-Flk-1/Flt-4 antibody (1020-1069 aa) (STJ93091) | ||||||||||||||||
|
||||||||||||||||||
Anti-FLT1 antibody (1016-1065 aa) (STJ93093) | Login | Anti-FLT1 antibody (1016-1065 aa) (STJ93093) | ||||||||||||||||
|
||||||||||||||||||
Anti-FLT3 antibody (565-614 aa) (STJ93095) | Login | Anti-FLT3 antibody (565-614 aa) (STJ93095) | ||||||||||||||||
|
||||||||||||||||||
Anti-FLT3LG antibody (171-220 aa) (STJ93096) | Login | Anti-FLT3LG antibody (171-220 aa) (STJ93096) | ||||||||||||||||
|
||||||||||||||||||
Anti-CEP43 antibody (341-390 aa) (STJ93101) | Login | Anti-CEP43 antibody (341-390 aa) (STJ93101) | ||||||||||||||||
|
||||||||||||||||||
Anti-FOXO1 antibody (295-344 aa) (STJ93126) | Login | Anti-FOXO1 antibody (295-344 aa) (STJ93126) | ||||||||||||||||
|
||||||||||||||||||
Anti-FOXO3 antibody (281-330 aa) (STJ93127) | Login | Anti-FOXO3 antibody (281-330 aa) (STJ93127) | ||||||||||||||||
|
||||||||||||||||||
Anti-FOXO3 antibody (220-269 aa) (STJ93128) | Login | Anti-FOXO3 antibody (220-269 aa) (STJ93128) | ||||||||||||||||
|
||||||||||||||||||
Anti-FOXO4 antibody (417-466 aa) (STJ93129) | Login | Anti-FOXO4 antibody (417-466 aa) (STJ93129) | ||||||||||||||||
|
||||||||||||||||||
Anti-FOXO4 antibody (164-213 aa) (STJ93130) | Login | Anti-FOXO4 antibody (164-213 aa) (STJ93130) | ||||||||||||||||
|
||||||||||||||||||
Anti-FZD1 antibody (15-64 aa) (STJ93138) | Login | Anti-FZD1 antibody (15-64 aa) (STJ93138) | ||||||||||||||||
|
||||||||||||||||||
Anti-FZD10 antibody (135-184 aa) (STJ93140) | Login | Anti-FZD10 antibody (135-184 aa) (STJ93140) | ||||||||||||||||
|
||||||||||||||||||
Anti-FZD2 antibody (201-250 aa) (STJ93141) | Login | Anti-FZD2 antibody (201-250 aa) (STJ93141) | ||||||||||||||||
|
||||||||||||||||||
Anti-FZD3 antibody (141-190 aa) (STJ93142) | Login | Anti-FZD3 antibody (141-190 aa) (STJ93142) | ||||||||||||||||
|